Johnson & Johnson Innovative Medicine Partner with Multiple Myeloma Ireland to Launch the 2025 “Miles for Myeloma” Challenge
Johnson & Johnson (J&J) staff embarked on the first mile of the 2025 ‘Miles for Myeloma’ challenge with Multiple Myeloma Ireland (MMI), kicking off the annual month-long challenge at the state-of-the-art biopharmaceutical site in Ringaskiddy, Cork.
This September, during Blood Cancer Awareness Month, the J&J team from Cork and the commercial organisation in Dublin have joined forces to walk, run, cycle and swim to clock up Miles for Myeloma and raise funds for this important cause.
MMI is the only charitable organisation in Ireland working to empower people affected by multiple myeloma and related conditions to live full lives, offer crucial support, education and advocacy. The longstanding partnership between J&J and MMI underscores a shared mission to advance patient care and support critical research, truly making a difference in the lives of those affected by this challenging disease.
Go to www.multiplemyelomaireland.org to find out more and sign up for the Miles for Myeloma challenge.
ABOUT JOHNSON & JOHNSON
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.
